{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T11:29:25Z","timestamp":1769858965873,"version":"3.49.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>As a rare subtype of primary lung adenocarcinoma (LUAD), mucinous pulmonary adenocarcinoma (MPA) was considered a distinctive entity with unfavorable outcomes. Therefore, there is a great need for a better understanding of the genomic and immunological landscape of this rare tumor type, which would inform improved therapeutic strategies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 96 patients histologically confirmed with MPA were recruited from Shandong Cancer Hospital and Institute (SCH). Single nucleotide variation (SNV), copy number variation (CNV), genomic instability, and immunological landscape insights into 96 MPA patients were identified using WES.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We demonstrated that MPAs had marked different genomic alterations and were more complex in genomic profiles than LUADs. Mutations in Tumor Protein 53 (<jats:italic>TP53<\/jats:italic>) and CYP7A Promoter-Binding Factor (<jats:italic>CPF)<\/jats:italic> pathways significantly shortened survival whereas mutations in <jats:italic>Notch<\/jats:italic> and <jats:italic>Wnt<\/jats:italic> pathways significantly prolonged survival in MPA. Besides, we demonstrated that mutations in immune-related genes influenced outcomes, with mutations in <jats:italic>TP53<\/jats:italic>, Ataxia Telangiectasia Mutated <jats:italic>(ATM)<\/jats:italic>, Polymerase (DNA) Delta 1 (<jats:italic>POLD1)<\/jats:italic>, and Epidermal Growth Factor Receptor <jats:italic>(EGFR)<\/jats:italic> correlated with worsened survival.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We not only depicted the genetic and immunologic landscape of Chinese MPA but also reveal its distinction from LUAD in genomic and immune context. Our findings may provide opportunities for therapeutic susceptibility among Chinese MPA patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2022.1054845","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T09:07:01Z","timestamp":1671095221000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Whole exome sequencing in Chinese mucinous pulmonary adenocarcinoma uncovers specific genetic variations different from lung adenocarcinoma"],"prefix":"10.3389","volume":"12","author":[{"given":"Chenyue","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiamao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenxiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenglong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangxiu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Airong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,15]]},"reference":[{"key":"B1","article-title":"WHO classification of tumours","volume-title":"Thoracic tumours","year":"2021"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e318206a221","article-title":"International association for the study of lung cancer\/american thoracic society\/european respiratory society international multidisciplinary classification of lung adenocarcinoma","volume":"6","author":"Travis","year":"2011","journal-title":"J Thorac Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.13632","article-title":"Spread through air spaces (STAS) in invasive mucinous adenocarcinoma of the lung: Incidence, prognostic impact, and prediction based on clinicoradiologic factors","volume":"11","author":"Lee","year":"2020","journal-title":"Thorac Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.37.2185","article-title":"The novel histologic international association for the study of lung Cancer\/American thoracic Society\/European respiratory society classification system of lung adenocarcinoma is a stage-independent predictor of survival","volume":"30","author":"Warth","year":"2012","journal-title":"J Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr.2017.06.10","article-title":"Biology of invasive mucinous adenocarcinoma of the lung","volume":"6","author":"Cha","year":"2017","journal-title":"Transl Lung Cancer Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2010.232","article-title":"Impact of proposed IASLC\/ATS\/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases","volume":"24","author":"oshizawa","year":"2011","journal-title":"Mod Pathol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nature13385","article-title":"Comprehensive molecular profiling of lung adenocarcinoma","volume":"511","year":"2014","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e318221f701","article-title":"Does lung adenocarcinoma subtype predict patient survival? a clinicopathologic study based on the new international association for the study of lung Cancer\/American thoracic Society\/European respiratory society international multidisciplinary lung adenocarcinoma classification","volume":"6","author":"Russell","year":"2011","journal-title":"J Thorac Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000579","article-title":"Unique genetic and survival characteristics of invasive mucinous adenocarcinoma of the lung","volume":"10","author":"Shim","year":"2015","journal-title":"J Thorac Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-0107","article-title":"Druggable oncogene fusions in invasive mucinous lung adenocarcinoma","volume":"20","author":"Nakaoku","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-018-05312-9","article-title":"New windows open for immunotherapy in lung cancer","volume":"558","author":"Hendriks","year":"2018","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bty560","article-title":"Fastp: an ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with burrows-wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp352","article-title":"1000 Genome project data processing subgroup. the sequence Alignment\/Map format and SAM tools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1101\/gr.107524.110","article-title":"The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-019-0569-6","article-title":"Genomic landscape of lung adenocarcinoma in East asians","volume":"52","author":"Chen","year":"2020","journal-title":"Nat Genet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"10131","DOI":"10.1038\/ncomms10131","article-title":"Frequent alterations in cytoskeleton remodelling genes in primary and metastatic lung adenocarcinomas","volume":"6","author":"Wu","year":"2015","journal-title":"Nat Commun"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2514","article-title":"Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples","volume":"31","author":"Cibulskis","year":"2013","journal-title":"Nat Biotechnol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/s41467-017-01358-x","article-title":"Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis","volume":"8","author":"Letouz\u00e9","year":"2017","journal-title":"Nat Commun"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu548","article-title":"OptiType: precision HLA typing from next-generation sequencing data","volume":"30","author":"Szolek","year":"2014","journal-title":"Bioinformatics"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/nature12213","article-title":"Et al: Mutational heterogeneity in cancer and the search for new cancer-associated genes","volume":"499","author":"Lawrence","year":"2013","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.cell.2017.09.042","article-title":"Universal patterns of selection in cancer and somatic tissues","volume":"171","author":"Martincorena","year":"2017","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btv408","article-title":"Somatic signatures: inferring mutational signatures from single-nucleotide variants","volume":"31","author":"Gehring","year":"2015","journal-title":"Bioinformatics"},{"key":"B25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13059-016-0893-4","article-title":"DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution","volume":"17","author":"Rosenthal","year":"2016","journal-title":"Genome Biol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-4-r41","article-title":"GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers","volume":"12","author":"Mermel","year":"2011","journal-title":"Genome Biol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","article-title":"Oncogenic signaling pathways in the cancer genome atlas","volume":"173","author":"Sanchez-Vega","year":"2018","journal-title":"Cell"},{"key":"B28","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.celrep.2018.03.076","article-title":"Genomic and molecular landscape of DNA damage repair deficiency across the cancer genome atlas","volume":"23","author":"Knijnenburg","year":"2018","journal-title":"Cell Rep"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.08.029","article-title":"Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing","volume":"150","author":"Mielinski M","year":"2012","journal-title":"Cell"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-021-00872-0","article-title":"Genomic characteristics of invasive mucinous adenocarcinoma of the lung with multiple pulmonary sites of involvement","volume":"35","author":"Kim","year":"2021","journal-title":"Mod Pathol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2858","article-title":"Genomic instability\u2013an evolving hallmark of cancer","volume":"11","author":"Negrini","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2013.02.018","article-title":"Nkx2-1 represses a latent gastric differentiation program in lung adenocarcinoma","volume":"50","author":"Snyder","year":"2013","journal-title":"Mol Cell"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2012.500","article-title":"Braf and erbB2 mutations correlate with smoking status in lung cancer patients","volume":"3","author":"Sasaki","year":"2012","journal-title":"Exp Ther Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"9504","DOI":"10.1200\/JCO.2020.38.15_suppl.9504","article-title":"Trastuzumab deruxtecan in patients with HER-2 mutated metastatic non-small cell lung cancer: interim results of DESTINY-Lung01","volume":"38","author":"Smit","year":"2020","journal-title":"J Clin Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1474-9726.2009.00475.x","article-title":"Aging and cancer cell biology, 2009","volume":"8","author":"Campisi","year":"2009","journal-title":"Aging Cell"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/35041694","article-title":"The age of cancer","volume":"408","author":"DePinho","year":"2000","journal-title":"Nature"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.8.10.8132","article-title":"Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissues","volume":"8","author":"Ma","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12606","article-title":"The role of complement inhibitors beyond controlling inflammation","volume":"282","author":"Blom","year":"2017","journal-title":"J Intern Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S338284","article-title":"CSMD1 mutation related to immunity can be used as a marker to evaluate the clinical therapeutic effect and prognosis of patients with esophageal cancer","volume":"14","author":"Fan","year":"2021","journal-title":"Int J Gen Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-009-0500-4","article-title":"Loss of CSMD1 expression is associated with high tumour grade and poor survival in invasive ductal breast carcinoma","volume":"121","author":"Kamal","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.23802","article-title":"Deregulation of CSMD1 targeted by microRNA-10b drives gastric cancer progression through the NF-\u03baB pathway","volume":"15","author":"Chen","year":"2019","journal-title":"Int J Biol Sci"},{"key":"B42","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.canlet.2019.10.027","article-title":"The superior efficacy of anti-PD-1\/PD-L1 immunotherapy in KRAS-mutant non-small cell lung cancer that correlates with an inflammatory phenotype and increased immunogenicity","volume":"470","author":"Liu","year":"2020","journal-title":"Cancer Lett"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2103695","article-title":"Sotorasib for lung cancers with KRAS p.G12C mutation","volume":"384","author":"Skoulidis","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.1054845\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T09:07:05Z","timestamp":1671095225000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.1054845\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,15]]},"references-count":43,"alternative-id":["10.3389\/fonc.2022.1054845"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.1054845","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,15]]},"article-number":"1054845"}}